To test whether CD3+CD8+ T cells were required for FMD-dependent sensitization of leukemia cells to VC, we selectively depleted CD8+ T lymphocytes using a neutralizing monoclonal antibody (αCD8) or an IgGa (control) (Figure 6c,e). This evidence concerns the gene CD8A and leukemia.